Updates on JAVELIN renal 101: primary treatment for patients
Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses the updated results seen in the JAVELIN renal 101 study…
Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, discusses the updated results seen in the JAVELIN renal 101 study…
Mitsuru Sasako, MD, PhD, Yodogawa Christian Hospital, Osaka, Japan, discusses the unpredictability of cancer outcomes, even in early-stage disease, based on his experience as a…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Myriam Chalabi, MD, Netherlands Cancer Institute, Amsterdam, Netherlands, comments on the promising results of neoadjuvant immunotherapy in patients with MMR-deficient (dMMR) colon cancer. While various…